MRK Merck Earnings and EPS analysis

EPS in 2025 (TTM): $6.89

Last Report Period Date: Mar 31, 2025

Currently, MRK's 12-month EPS stands at $6.89, according to the most recent financial reports. Merck's earnings per share in 2024 was reported at $6.76, marking a rise from $0.14 in 2023. MRK recorded an EPS of $2.01 for the quarterly period ending on Mar 31, 2025.

In 2024, Merck's earnings per share was $6.76, a rise of 4,728.6% from $0.14 in 2023. The quarterly earnings per share for the period ending Mar 31, 2025, was $2.01, showing a 6.9% increase compared to the same quarter last year. The trailing twelve months EPS for MRK is $6.89 as of March 2025. Merck's full-year EPS for 2023 was $0.14, a 97.6% decline compared to the previous year.

Merck has recorded a growth in earnings per share of 6.9% in the past 12 months (YoY, quarterly). During the past three years, MRK registered an average yearly EPS growth of 9.4%. Merck had an average annual EPS growth of 12% in the last five years. Over the last decade, MRK had an average annual earnings per share growth of 5.1%.